Education
About Us
Working with TipRanks
Follow Us
Iradimed Corp (IRMD)
:IRMD
IRMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$42.34 - $66.50
Previous CloseN/A
Volume15.52K
Average Volume (3M)54.73K
Market Cap
$841.36M
Enterprise Value$714.43M
Total Cash (Recent Filing)$50.33M
Total Debt (Recent Filing)$59.22K
Price to Earnings (P/E)41.0
Beta0.73
Next Earnings
Oct 31, 2025EPS Estimate
0.46Next Dividend Ex-Date
Aug 18, 2025Dividend Yield0.97%
Share Statistics
EPS (TTM)0.49
Shares Outstanding12,715,109
10 Day Avg. Volume43,763
30 Day Avg. Volume54,731
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue9.51
Enterprise Value/Gross Profit12.36
Enterprise Value/Ebitda30.30
Forecast
1Y Price Target
$71.00Price Target Upside7.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Iradimed News
IRMD FAQ
What was Iradimed Corp’s price range in the past 12 months?
Iradimed Corp lowest stock price was $42.34 and its highest was $66.50 in the past 12 months.
What is Iradimed Corp’s market cap?
Iradimed Corp’s market cap is $841.36M.
When is Iradimed Corp’s upcoming earnings report date?
Iradimed Corp’s upcoming earnings report date is Oct 31, 2025 which is in 87 days.
How were Iradimed Corp’s earnings last quarter?
Iradimed Corp released its earnings results on Aug 01, 2025. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.435 by $0.055.
Is Iradimed Corp overvalued?
According to Wall Street analysts Iradimed Corp’s price is currently Undervalued.
Does Iradimed Corp pay dividends?
Iradimed Corp pays a Quarterly dividend of $0.17 which represents an annual dividend yield of 0.97%. See more information on Iradimed Corp dividends here
What is Iradimed Corp’s EPS estimate?
Iradimed Corp’s EPS estimate is 0.46.
How many shares outstanding does Iradimed Corp have?
Iradimed Corp has 12,715,109 shares outstanding.
What happened to Iradimed Corp’s price movement after its last earnings report?
Iradimed Corp reported an EPS of $0.49 in its last earnings report, beating expectations of $0.435. Following the earnings report the stock price went up 13.421%.
Which hedge fund is a major shareholder of Iradimed Corp?
Currently, no hedge funds are holding shares in IRMD
Iradimed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$71.00 (7.30% Upside)
$71.00 (7.30% Upside)
Blogger Sentiment
Bullish
IRMD Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 11.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 1.3%
Last 30 Days ▲ 1.3%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
61.18%
12-Months-Change
Fundamentals
Return on Equity
23.75%
Trailing 12-Months
Asset Growth
18.34%
Trailing 12-Months
Company Description
Iradimed Corp
Iradimed Corporation (IRMD) is a leading provider of innovative magnetic resonance imaging (MRI) compatible medical devices. The company specializes in developing and commercializing advanced MRI-compatible patient monitoring systems and non-magnetic infusion pumps. These products are designed to meet the unique needs of MRI environments, ensuring patient safety and compliance with strict regulatory standards. Iradimed's solutions are widely used in hospitals and medical facilities around the world, catering to a critical niche in the healthcare sector.
IRMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a predominantly positive outlook with record revenues, strong earnings growth, and the successful launch of a new product line. However, some challenges remain, such as a decline in international sales and potential operational inefficiencies. Overall, the company shows a strong trajectory for growth.Read More>IRMD Stock 12 Month Forecast
Average Price Target
$71.00
▲(7.30%Upside)
Technical Analysis
Ownership Overview
0.77% Insiders
9.86% Mutual Funds
0.65% Other Institutional Investors
80.48% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---